A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by Amgen.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Amgen
Collaborator:
Daiichi Sankyo Inc.
Information provided by:
Amgen
ClinicalTrials.gov Identifier:
NCT00321464
First received: May 2, 2006
Last updated: July 1, 2010
Last verified: July 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2011 |
| Estimated Primary Completion Date: | July 2009 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | June 29, 2010 |